Visit us at EHA

Oncopeptides presented clinical results from an ongoing Phase I/II study in patients with relapsed and relapsed refractory multiple myeloma in combination with dexamethasone at the European Hematology Association meeting in Vienna.

Upcoming events

Silent Period

-

Interim Report Q2 2021

08:00 CET

Silent Period

-

Interim Report Q3 2021

08:00 CET